Inherited Cardiomyopathies

被引:112
|
作者
Towbin, Jeffrey A. [1 ]
机构
[1] Cincinnati Childrens Hosp Med Ctr, Inst Heart, Cincinnati, OH 45229 USA
关键词
Cardiomyopathy; Genetics; Heart failure; RIGHT-VENTRICULAR CARDIOMYOPATHY/DYSPLASIA; FINAL COMMON PATHWAY; DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; HEART-FAILURE; ISOLATED NONCOMPACTION; MOLECULAR-MECHANISMS; GENETIC EVALUATION; MUTATIONS; DYSTROPHIN;
D O I
10.1253/circj.CJ-14-0893
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiomyopathies (ie, diseases of the heart muscle) are major causes of morbidity and mortality. A significant percentage of patients with cardiomyopathies have genetic-based, inheritable disease and, over the past 2 decades the genetic causes of these disorders have been increasingly discovered. The genes causing these disorders when they are mutated appear to encode proteins that frame a "final common pathway" for that specific disorder, but the specifics of the phenotype, including age of onset, severity, and outcome is variable for reasons not yet understood. The "final common pathways" for the classified forms of cardiomyopathy include the sarcomere in the primarily diastolic dysfunction disorders hypertrophic cardiomyopathy and restrictive cardiomyopathy, the linkage of the sarcomere and sarcolemma in the systolic dysfunction disorder dilated cardiomyopathy, and the desmosome in arrhythmogenic cardiomyopathy. Left ventricular noncompaction cardiomyopathy (LVNC) is an overlap disorder and it appears that any of these "final common pathways" can be involved depending on the specific form of LVNC. The genetics and mechanisms responsible for these clinical phenotypes will be described.
引用
收藏
页码:2347 / 2356
页数:10
相关论文
共 50 条
  • [41] Multimodality Imaging for Risk Assessment of Inherited Cardiomyopathies
    Jack W. O’Sullivan
    June Rhee
    David Hsu
    Matthew T. Wheeler
    Koen Nieman
    Current Cardiovascular Risk Reports, 2020, 14
  • [42] Myocardial Inflammation and Sudden Death in the Inherited Cardiomyopathies
    McKenna, William J.
    Caforio, Alida L. P.
    CANADIAN JOURNAL OF CARDIOLOGY, 2022, 38 (04) : 427 - 438
  • [43] New therapies to treat inherited cardiomyopathies are on the way
    P. Vlasman
    J. van der Velden
    Netherlands Heart Journal, 2022, 30 : 63 - 64
  • [44] Alpha-tropomyosin mutations in inherited cardiomyopathies
    Redwood, Charles
    Robinson, Paul
    JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY, 2013, 34 (3-4) : 285 - 294
  • [45] Alpha-tropomyosin mutations in inherited cardiomyopathies
    Charles Redwood
    Paul Robinson
    Journal of Muscle Research and Cell Motility, 2013, 34 : 285 - 294
  • [46] Neuromuscular, pathological and genetic investigation in inherited cardiomyopathies
    Limongelli, G.
    Sampaolo, S.
    Frisso, G.
    Pacileo, G.
    Salvatore, F.
    Di Iorio, G.
    Calabro, R.
    EUROPEAN HEART JOURNAL, 2016, 37 : 365 - 366
  • [47] Systematic review of pregnancy in women with inherited cardiomyopathies
    Krul, Sebastien P. J.
    van der Smagt, Jasper J.
    van den Berg, Maarten P.
    Sollie, Krystyna M.
    Pieper, Petronella G.
    van Spaendonck-Zwarts, Karin Y.
    EUROPEAN JOURNAL OF HEART FAILURE, 2011, 13 (06) : 584 - 594
  • [48] Molecular genetics profile of inherited cardiomyopathies in Bahrain
    Skrypnyk, Cristina
    Kalis, Neale
    Sulaibeekh, Leena
    Lynch, Mary Jozeph
    Khalifa, Adel
    Ben Khalaf, Noureddine
    AlShammary, Sfoug
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2023, 31 : 143 - 143
  • [49] Genome Editing for the Understanding and Treatment of Inherited Cardiomyopathies
    Quynh Nguyen
    Lim, Kenji Rowel Q.
    Yokota, Toshifumi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (03)
  • [50] Multimodality Imaging for Risk Assessment of Inherited Cardiomyopathies
    O'Sullivan, Jack W.
    Rhee, June
    Hsu, David
    Wheeler, Matthew T.
    Nieman, Koen
    CURRENT CARDIOVASCULAR RISK REPORTS, 2020, 14 (05)